论文部分内容阅读
Objective: To observe supplemented inula--Ochrae Decoction (SIOD) in preventing andtreating nausea and vomiting induced bychemotherapy for patients with malignant tumour. Methods: Seventy--two patients weredivided into two groups, the patients in testgroup took SIOD and in control group usingondensetron, and the efficacy of SIOD in preventing and treating chemotherapy inducednausea and vomiting were studied prospectively with self--intersection approach. Results:The effective rate of treating vomiting due tochemotherapy with DDP and without DDP inthe test group was 92. 7 % and 93. 5 % respectively, and was higher than that in the controlgroup 87. 8 % and 87. 1 %, the difference wasinsignificant statistically (P > 0. 05 ). Conclusions f The prescription SIOD could preventand treat effectively chemotherapy inducednausea and vomiting without any toxic andside effects, and is inexpensive with high efficacy for clinical use.
Objective: To observe supplemented inula--Ochrae Decoction (SIOD) in preventing and treating nausea and vomiting induced bychemotherapy for patients with malignant tumour. Methods: Seventy--two patients weredivided into two groups, the patients in testgroup took SIOD and in control group usingondensetron , and the efficacy of SIOD in preventing and treating chemotherapy inducednausea and vomiting was investigated prospectively with self--intersection approach. Results:The effective rate of treating vomiting due tochemotherapy with DDP and without DDP inthe test group was 92. 7 % and 93. 5 % respectively, and was higher than that in the controlgroup 87. 8 % and 87. 1 %, the difference was insignificant ly (P > 0. 05 ). Conclusions f The prescription SIOD could prevent and treat cancer chemotherapy inducednausea and vomiting without any toxic Andside effects, and is inexpensive with high efficacy for clinical use.